Jussara Pereira do Nascimento
Biographic Data
| ID | 5608501 |
|---|---|
| NAME | Jussara Pereira do Nascimento |
| GIVEN NAMES | Jussara Pereira |
| FAMILY NAME | do Nascimento |
| SIGNATURE | DO NASCIMENTO J P |
| AFFILIATIONS | Fiocruz, Brasil |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 8 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2004 |
| LATEST PUBLICATION YEAR | 2005 |
| H-INDEX | 2 |
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
OBJECTIVE: To compare the reactogenicity of three yellow fever (YF) vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots) and placebo. METHODS: The study involved 1,087 adults eligible for YF vaccine in Rio de Janeiro, Brazil. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered ("day 0") following standardized procedures adapted to allow blinding and blocked randomization of participants to …
Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: A randomized trial
OBJECTIVE: To compare the immunogenicity of three yellow fever vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots). METHODS: An equivalence trial was carried out involving 1,087 adults in Rio de Janeiro. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered following standardized procedures adapted to allow blocked randomized allocation of participants to coded vaccine types (double-blind). …
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
OBJECTIVE: To compare the reactogenicity of three yellow fever (YF) vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots) and placebo. METHODS: The study involved 1,087 adults eligible for YF vaccine in Rio de Janeiro, Brazil. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered ("day 0") following standardized procedures adapted to allow blinding and blocked randomization of participants to …
Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: A randomized trial
OBJECTIVE: To compare the immunogenicity of three yellow fever vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots). METHODS: An equivalence trial was carried out involving 1,087 adults in Rio de Janeiro. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered following standardized procedures adapted to allow blocked randomized allocation of participants to coded vaccine types (double-blind). …
Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines: A randomized trial
OBJECTIVE: To compare the immunogenicity of three yellow fever vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots). METHODS: An equivalence trial was carried out involving 1,087 adults in Rio de Janeiro. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered following standardized procedures adapted to allow blocked randomized allocation of participants to coded vaccine types (double-blind). …
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
OBJECTIVE: To compare the reactogenicity of three yellow fever (YF) vaccines from WHO-17D and Brazilian 17DD substrains (different seed-lots) and placebo. METHODS: The study involved 1,087 adults eligible for YF vaccine in Rio de Janeiro, Brazil. Vaccines produced by Bio-Manguinhos, Fiocruz (Rio de Janeiro, Brazil) were administered ("day 0") following standardized procedures adapted to allow blinding and blocked randomization of participants to …
Malaria Research and Control (2 works) · Mosquito-borne diseases and control (2 works) · Seroconversion (2 works) · Yellow fever vaccine (2 works) · Adverse effect (1 works) · Alternative medicine (1 works) · Antibody (1 works) · Immune system (1 works) · Immunization (1 works) · Immunology (1 works)